Exploitation of CD133 for the targeted imaging of lethal prostate cancer

PURPOSE: Aggressive variant prostate cancer (AVPC) is a non-androgen receptor-driven form of disease that arises in men who have failed standard-of-care therapies. Therapeutic options for AVPC are limited, and the development of novel therapeutics is significantly hindered by the inability to accura...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Cancer Res
Главные авторы: Glumac, Paige M., Gallant, Joseph P., Shapovalova, Mariya, Li, Yingming, Murugan, Paari, Gupta, Shilpa, Coleman, Ilsa M., Nelson, Peter S., Dehm, Scott M., LeBeau, Aaron M.
Формат: Artigo
Язык:Inglês
Опубликовано: 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056526/
https://ncbi.nlm.nih.gov/pubmed/31732520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1659
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы